Delivering integrated expertise across clinical, operational, and technology domains to solve healthcare's most complex challenges. MARBLEHEAD, Mass., Oct. 21, 2024...
MADISON, Wis., Oct. 21, 2024 /PRNewswire/ -- Yahara Software, a leader in custom software development, has been awarded the prestigious...
RIYADH, Saudi Arabia, Oct. 21, 2024 /PRNewswire/ -- The seventh edition of the Global Health Exhibition has kicked off under the...
Two ISO-Certified Industry Leaders Collaborate to Provide Fertility Clinics with Complete, Trusted Solutions for Secure IVF Specimen Management and Transport...
New framework addresses critical challenges to clinical AI development and integration NEW YORK, Oct. 21, 2024 /PRNewswire/ -- Aidoc, a...
PARIS, Oct. 21, 2024 /PRNewswire/ -- Okomera announces Bpifrance funding to develop and standardize novel CRISPR screening assay to accelerate drug...
DENVER, Oct. 21, 2024 /PRNewswire/ -- Infermedica, the leading global digital health company specializing in AI-powered solutions for symptom analysis and...
SHANGHAI and MIDDLETOWN, Del., Oct. 21, 2024 /PRNewswire/ -- HuidaGene Therapeutics ("HuidaGene"), a global clinical-stage biotechnology company pioneering CRISPR-based programmable genome medicines,...
The analysis is being presented this week at the American College of Surgeons Clinical Congress 2024 (ACS 2024) in San...
BELLEVUE, WA / ACCESSWIRE / October 21, 2024 / Medbridge, a leader in healthcare technology solutions, today announced its acquisition...
SAN FRANCISCO, CA / ACCESSWIRE / October 21, 2024 / Ambience Healthcare - the leading clinical AI platform for scribing,...
Christian Attar Law Firm and Freedman Normand Friedland LLP, in conjunction with forensic investigators, have uncovered evidence of a potential...
Management to Showcase New Nature-Cide Rat and Mouse Repellent Pouches Alongside Broader Nature-Cide Product Portfolio at Leading Industry Conference LOS...
MIAMI, FL / ACCESSWIRE / October 21, 2024 / MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA), a leading pre-clinical-stage pharmaceutical development company, is...
ZURICH, SWITZERLAND / ACCESSWIRE / October 21, 2024 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage...
Vancouver, British Columbia--(Newsfile Corp. - October 21, 2024) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi" or...
Report Cites Projections of an Additional $3.5 Billion Upon Global Expansion STUART, Fla., Oct. 21, 2024 /PRNewswire/ -- Base Molecular...
STOCKHOLM, Oct. 21, 2024 /PRNewswire/ -- Analysts, investors, and the media are invited to a presentation of RaySearch's interim report...
Upon authorization by the European Commission, KORJUNY® will be the only drug approved and available for the intraperitoneal treatment of...
LUND, SE / ACCESSWIRE / October 21, 2024 / Spago Nanomedical (STO:SPAGO.ST)(FRA:7UX.F) In accordance with the instructions to the nomination...